The expertise of specialized pharmacists enables them to circumvent insurance barriers, improve adherence rates, and contribute to healthcare cost savings.
About 39% of people in the United States have utilized these substances for therapeutic purposes, spurring investigation into their potential for preventing and treating some diseases.
Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.
Janus kinase inhibitors effectively treat rheumatoid arthritis, but their use in smokers aged older than 65 years and certain other populations potentiates the risk of adverse events.